相似文献
1
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
J Am Coll Cardiol. 2019 Jul 30;74(4):567-577. doi: 10.1016/j.jacc.2019.06.007.
2
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
J Am Coll Cardiol. 2019 Jul 30;74(4):578-586. doi: 10.1016/j.jacc.2019.05.045.
3
Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors.
Circ J. 2023 Feb 24;87(3):394-400. doi: 10.1253/circj.CJ-21-0505. Epub 2021 Aug 25.
4
Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
Transl Res. 2023 May;255:152-158. doi: 10.1016/j.trsl.2022.08.013. Epub 2022 Sep 5.
5
Clonal hematopoiesis and associated diseases: A review of recent findings.
Cancer Sci. 2021 Oct;112(10):3962-3971. doi: 10.1111/cas.15094. Epub 2021 Aug 12.
6
Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Curr Cardiol Rep. 2022 Aug;24(8):1049-1058. doi: 10.1007/s11886-022-01724-2. Epub 2022 Jun 3.
7
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Curr Oncol Rep. 2023 Jun;25(6):539-547. doi: 10.1007/s11912-023-01382-9. Epub 2023 Mar 16.
8
Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
Annu Rev Pathol. 2020 Jan 24;15:419-438. doi: 10.1146/annurev-pathmechdis-012419-032544. Epub 2019 Nov 5.
9
Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
Circ Res. 2018 Feb 2;122(3):523-532. doi: 10.1161/CIRCRESAHA.117.312115.
10
Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
J Mol Cell Cardiol. 2021 Dec;161:98-105. doi: 10.1016/j.yjmcc.2021.07.004. Epub 2021 Jul 21.
引用本文的文献
1
Inflammatory signaling in the pathogenesis of acute myeloid leukemia.
Hemasphere. 2025 Aug 13;9(8):e70188. doi: 10.1002/hem3.70188. eCollection 2025 Aug.
2
Clonal Hematopoiesis of Intermediate Potential in Atrial Fibrillation: A Critical View of Current Knowledge as a Springboard for Future Research.
Diagnostics (Basel). 2025 Jul 30;15(15):1915. doi: 10.3390/diagnostics15151915.
3
Impact of clonal hematopoiesis of indeterminate potential on arterial atherothrombosis and venous thromboembolism: Protocol for a systematic review and meta-analysis.
PLoS One. 2025 Jul 16;20(7):e0328650. doi: 10.1371/journal.pone.0328650. eCollection 2025.
4
Diagnosis and Management of Atrial Arrhythmias in Cancer Patients.
Curr Cardiol Rep. 2025 Jun 25;27(1):103. doi: 10.1007/s11886-025-02261-4.
5
Clonal haematopoiesis of indeterminate potential: a risk factor for future exacerbation in patients with COPD.
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00292-2024. eCollection 2025 May.
6
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis.
EClinicalMedicine. 2025 Jun 5;84:103274. doi: 10.1016/j.eclinm.2025.103274. eCollection 2025 Jun.
7
Association of clonal hematopoiesis of indeterminate potential with cardiometabolic multimorbidity progression and mortality: a prospective study of UK Biobank.
Eur J Med Res. 2025 May 24;30(1):414. doi: 10.1186/s40001-025-02639-8.
8
Deciphering TP53 Mosaic Variants on Germline Biomarker Testing: Implications for Oncology Nurses.
Clin J Oncol Nurs. 2025 May 19;29(3):201-206. doi: 10.1188/25.CJON.201-206.
9
Epigenome-wide DNA methylation association study of CHIP provides insight into perturbed gene regulation.
Nat Commun. 2025 May 20;16(1):4678. doi: 10.1038/s41467-025-59333-w.
10
Prognostic significance of clonal hematopoiesis in STEMI: a 10-year follow-up reveals high-risk gene mutations.
Hum Genomics. 2025 May 12;19(1):51. doi: 10.1186/s40246-025-00757-2.
本文引用的文献
1
Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.
Cardiovasc Res. 2019 Apr 15;115(5):824-829. doi: 10.1093/cvr/cvz058.
2
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.
Circulation. 2019 Mar 26;139(13):e579-e602. doi: 10.1161/CIR.0000000000000641.
3
Hemothelium, Clonal Hematopoiesis of Indeterminate Potential, and Atherosclerosis.
Circulation. 2019 Jan 2;139(1):7-9. doi: 10.1161/CIRCULATIONAHA.118.038434.
4
Jak-ing Up the Plaque's Lipid Core…and Even More.
Circ Res. 2018 Nov 9;123(11):1180-1182. doi: 10.1161/CIRCRESAHA.118.314074.
5
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 Mice.
Circ Res. 2018 Nov 9;123(11):e35-e47. doi: 10.1161/CIRCRESAHA.118.313283.
6
CHIPping Away at the Pathogenesis of Heart Failure.
JAMA Cardiol. 2019 Jan 1;4(1):5-6. doi: 10.1001/jamacardio.2018.4039.
7
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
JAMA Cardiol. 2019 Jan 1;4(1):25-33. doi: 10.1001/jamacardio.2018.3965.
8
Managing Clonal Hematopoiesis in Patients With Solid Tumors.
J Clin Oncol. 2019 Jan 1;37(1):7-11. doi: 10.1200/JCO.18.00331. Epub 2018 Nov 7.
9
The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).
J Am Coll Cardiol. 2018 Oct 30;72(18):2213-2230. doi: 10.1016/j.jacc.2018.08.2149.
10
CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk.
Circulation. 2018 Aug 14;138(7):666-668. doi: 10.1161/CIRCULATIONAHA.118.034392.
Zotero 插件